Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
24th March 2026 Uncategorised 0Abivax has appointed Michael Nesrallah as its chief commercial officer, putting one of the people who turned Entyvio into a blockbuster in charge of preparations for its ulcerative colitis launch. More: Abivax hires commercial chief from Takeda to infuse Entyvio
read more
